<http://webisa.webdatacommons.org/prov/61104487>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/169975589> .
<http://webisa.webdatacommons.org/169975589>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/169975589>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/169975589>	<http://www.w3.org/ns/prov#value>	"f IGF-I and IGF-II. If the antibody is able to cause IGF-IR activation in the absence of IGF-I and IGF-II, e.g., it increases IGF-IR tyrosine phosphorylation, and then the antibody is a mimic antibody." .